IGC Pharma, Inc.
IGC- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001326205
No open-market purchases or sales by IGC Pharma, Inc. insiders were filed in the last 90 days; 36 institutions reported holding it in 13F filings for Q2 2026, worth $1.41M in total; no superinvestor holds it.
Q2 2025 vs. Q1 2025
How the institutions holding IGC Pharma, Inc. changed between Q1 2025 and Q2 2025.
All holders in Q2 2025All holders in Q1 2025
| Measure | Q1 2025 | Q2 2025 | Change |
|---|---|---|---|
| Holders | 25 | 28 | +3 |
| Shares | 2.86M | 3.04M | +178.4K (+6.2%) |
| Value | $814.9K | $929.4K | +$114.5K (+14.0%) |
New holders (5)
Institutions that held IGC Pharma, Inc. at the end of Q2 2025 but not at the end of Q1 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Renaissance Technologies LLC | 55,025 | $16.8K | 0.00% |
| Virtu Financial LLC | 46,892 | $14.0K | 0.00% |
| Jane Street Group, LLC | 13,316 | $4.08K | 0.00% |
| Two Sigma Securities, LLC | 11,834 | $3.62K | 0.00% |
| Raymond James Financial Inc | 178 | $55 | 0.00% |
Sold out (2)
Institutions that held IGC Pharma, Inc. at the end of Q1 2025 and filed for Q2 2025 without it.
| Institution | Shares, Q1 2025 | Value, Q1 2025 |
|---|---|---|
| Squarepoint Ops LLC | 140,510 | $40.0K |
| GWM Advisors LLC | 14 | $4 |